736MO Personalized, off-the-shelf KRAS neoantigen-specific immunotherapy for the treatment of advanced solid tumors: Clinical benefit associated with decreases in ctDNA (SLATE-KRAS)
| Autor: | Kyi, C.K., Spira, A., Carbone, D.P., Johnson, M.L., Henick, B.S., Johnson, B., Borghaei, H., Mahipal, A., Hecht, J.R., Catenacci, D., Liao, C-Y., Shergill, A., Memmott, R., Presley, C., Jaroslavsky, J., Schenk, D., Jooss, K., Ferguson, A.R., Goldman, J.W. |
|---|---|
| Zdroj: | In Annals of Oncology September 2022 33 Supplement 7:S880-S880 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|